A combination of drugs may do the trick for multiple myelomaLenalidomide and Dexamethasone, two drugs when taken in a combination, can prove useful for providing significant relief to patients afflicted with multiple myeloma. This finding was disclosed by a study that was conducted at 44 centers in the United States and Canada and involved 353 patients with myeloma.

Progression of myeloma can be slowed down with the pairing of a new derivative of thalidomide with a steroid and this combination could prolong lives of patients who have relapsed from treatments in the past.

Lead author Donna Weber, M.D., associate professor in the Department of Lymphoma and Myeloma at the University of Texas M. D. Anderson Cancer Center, remarked that this combination can do the trick particularly when the disease becomes immune to one therapy.